Neuraura is a cutting-edge brand that aims to revolutionize the treatment of brain and metabolic-related disorders. With a mission to unlock safe and effective treatments, Neuraura is tackling neurological and metabolomic conditions, which have become a global epidemic. By utilizing its proprietary sensing technology, Neuraura aims to understand the electrical workings of the brain and body for personalized and adaptive care.

The brand combines the expertise of world-class researchers, healthcare professionals, and medical organizations to create a neuro care system that prioritizes patient and clinician experience. Neuraura was formed as a spin-out from the University of Calgary, in collaboration with the Hotchkiss Brain Institute and the Schulich School of Engineering. The leadership team, including co-founders Claire Dixon, Pierre Wijdenes, and Colin Dalton, brings extensive experience in strategy, operations, and biomedical engineering.

Supported by a team of distinguished advisors with expertise in areas such as business and clinical practice, Neuraura is poised to push the boundaries of innovation. Their goal is to develop groundbreaking treatments and products that empower patients and transform the field of neurology. With offices in Calgary, Canada, and Melbourne, Australia, Neuraura is at the forefront of pioneering advancements in healthcare